In the second part of the Uromigos’ EAU coverage, Dr. Matt Galsky describes the OS signal data from CheckMate-274, which analyzed the use of adjuvant nivolumab in patients with muscle-invasive bladder cancer. Brian, Tom, and Matt also discuss the future of bladder cancer care and research. ...
The Uromigos: EAU
Hear Thomas Powles, MD, and Brian Rini, MD, FASCO, discuss research and news from the annual EAU Congress.
Advertisement
Dr. Matt Galsky, Brian, and Tom discuss the IMvigor011 trial data that was presented at EAU 2024.
Betsy Plimack discusses the tricks of the trade for adverse event management.
Dr. Ashish Kamat walks through ongoing issues around surgery in urothelial cancer at EAU 2021.
Peter Albers talks about exciting updates in prostate cancer research and picks his three highlights from EAU21.
Dr. Grant Stewart discusses renal cancer data presented at the 2021 EAU Conference.
Advertisement
